Birgit Girshick, Corporate Executive VP at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 8,675 shares at $136.93 ($1.2M) on 2019-11-13, disclosed to the SEC on 2019-11-14.
Open-market sale of $1.2M CRL by Corporate Executive VP. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.93 | 96 | $13K | 1.1% |
| 2 | $136.94 | 401 | $55K | 4.6% |
| 3 | $136.95 | 350 | $48K | 4.0% |
| 4 | $136.96 | 208 | $28K | 2.4% |
| 5 | $136.97 | 195 | $27K | 2.2% |
| 6 | $136.97 | 177 |
| $24K |
| 2.0% |
| 7 | $136.98 | 177 | $24K | 2.0% |
| 8 | $136.98 | 192 | $26K | 2.2% |
| 9 | $136.99 | 65 | $9K | 0.7% |
| 10 | $136.99 | 503 | $69K | 5.8% |
| 11 | $136.99 | 65 | $9K | 0.7% |
| 12 | $137.00 | 713 | $98K | 8.2% |
| 13 | $137.00 | 77 | $11K | 0.9% |
| 14 | $137.01 | 791 | $108K | 9.1% |
| 15 | $137.01 | 77 | $11K | 0.9% |
| 16 | $137.02 | 193 | $26K | 2.2% |
| 17 | $137.03 | 51 | $7K | 0.6% |
| 18 | $137.03 | 51 | $7K | 0.6% |
| 19 | $137.03 | 52 | $7K | 0.6% |
| 20 | $137.05 | 1,314 | $180K | 15.1% |
| 21 | $137.06 | 100 | $14K | 1.2% |
| 22 | $137.06 | 100 | $14K | 1.2% |
| 23 | $137.06 | 100 | $14K | 1.2% |
| 24 | $137.07 | 100 | $14K | 1.2% |
| 25 | $137.08 | 100 | $14K | 1.2% |
| 26 | $137.09 | 201 | $28K | 2.3% |
| 27 | $137.10 | 134 | $18K | 1.5% |
| 28 | $137.11 | 100 | $14K | 1.2% |
| 29 | $137.12 | 676 | $93K | 7.8% |
| 30 | $137.13 | 249 | $34K | 2.9% |
| 31 | $137.14 | 767 | $105K | 8.8% |
| 32 | $137.15 | 300 | $41K | 3.5% |
| Total | $137.04 avg | 8,675 | $1.2M | 100% |
| Filing → |
| CRL | BUY | 2023-11-21 | $497K | — | Filing → |
| CRL | SELL | 2023-02-17 | $1.5M | — | Filing → |
| CRL | SELL | 2021-09-15 | $2.1M | — | Filing → |